Valuation: Supergenics

Market Cap 29.11M 7.12M 6.25M 5.84M 5.36M 10.03M 682M 10.28M 69.22M 27.07M 337M 26.72M 26.14M 1.17B P/E 2024
-9.45x
P/E 2025 -8.61x
Enterprise Value 32.5M 7.95M 6.98M 6.52M 5.98M 11.2M 761M 11.47M 77.3M 30.23M 377M 29.84M 29.19M 1.3B EV / Sales 2024
13.9x
EV / Sales 2025 5.78x
Free-Float
41.6%
Yield 2024 *
-
Yield 2025 -
1 year 0.2
Extreme 0.205
0.25
3 years 0.15
Extreme 0.15
0.6
5 years 0.15
Extreme 0.15
0.6
10 years 0.15
Extreme 0.15
0.6
Manager TitleAgeSince
Chief Executive Officer 48 24/04/2019
Corporate Secretary - 02/06/2022
Director TitleAgeSince
Director/Board Member 48 24/04/2019
Director/Board Member 60 24/04/2019
Director/Board Member 46 28/01/2022
Change 5-day change 1-year change 3-year change Capi.($)
+21.95%-.--%-16.67%+13.64% 7.12M
+0.26%+5.13%-0.73%+12.83% 48.95B
+1.90%+24.70%+27.25%+9.47% 40.75B
-1.60%-1.15%+388.84%+603.70% 38.46B
-0.98%+2.28%+7.02%+45.34% 36.38B
+1.47%+5.82%+5.76%+43.52% 28.45B
-0.94%+0.05% - - 16.62B
+2.44%+10.76%+30.59%+129.56% 16.33B
-1.14%+6.52%-3.80%-29.33% 13.65B
+0.35%+3.96%+4.03%+9.84% 13.56B
Average +2.33%+5.21%+49.14%+93.17% 25.31B
Weighted average by Cap. +0.14%+6.92%+71.67%+122.48%

Financials

2024 2025
Net sales 5.32M 1.3M 1.14M 1.07M 980K 1.83M 125M 1.88M 12.66M 4.95M 61.68M 4.89M 4.78M 213M 5.63M 1.38M 1.21M 1.13M 1.04M 1.94M 132M 1.99M 13.38M 5.23M 65.2M 5.16M 5.05M 225M
Net income -7.28M -1.78M -1.56M -1.46M -1.34M -2.51M -171M -2.57M -17.32M -6.77M -84.38M -6.68M -6.54M -292M -3.37M -823K -723K -675K -619K -1.16M -78.83M -1.19M -8M -3.13M -39.01M -3.09M -3.02M -135M
Net Debt 4.48M 1.09M 962K 898K 824K 1.54M 105M 1.58M 10.65M 4.16M 51.89M 4.11M 4.02M 179M 3.39M 830K 729K 681K 625K 1.17M 79.49M 1.2M 8.07M 3.16M 39.34M 3.12M 3.05M 136M
Logo Supergenics
Supergenics Berhad is a Malaysia-based management and investment holding company. The Company operates through three segments: Integrated Turnkey Solutions, Biomedical, and Investment Holding. Its Integrated Turnkey Solutions segment is engaged in the provision of integrated turnkey solutions for the related development of cleanrooms and the provision of related maintenance services. Its Biomedical segment is engaged in the provision of administrative health care services, operating medical laboratories, and developing regenerative wellness products. The Company provides laboratory services, including storage and handling of stem cell samples. Its services include stem cells, mesenchymal stem cells (MSC), natural killer (NK) cells, exosomes, and MSC exosomes. Its subsidiaries include Supergenics Solution Sdn. Bhd., Supergenics Life Science Sdn. Bhd., Supergenics Therapeutic Sdn. Bhd., Supergenics Bio Agro Sdn. Bhd., Supergenics Stembank Sdn. Bhd., and Supergenics Global Sdn. Bhd.
Employees
-
  1. Stock Market
  2. Stocks
  3. 03033 Stock